Literature DB >> 1357682

The effects of neuroleptics on facial action in schizophrenic patients.

F Schneider1, H Ellgring, J Friedrich, I Fus, T Beyer, H Heimann, W Himer.   

Abstract

This paper describes the influence of neuroleptic therapy on facial action in drug-naive schizophrenics. In a comparative study of medicated and unmedicated schizophrenic patients, the coordinates of 12 small light-reflecting points, attached to subjects' faces, were computer-recorded and analyzed automatically during a semi-standardized clinical interview. In addition, facial activity in videotaped interviews was coded using the Facial Action Coding System (FACS). Each sample group comprised of eight patients with the DSM-III-R diagnostic criteria "schizophrenia" or "schizophreniform disorder". Subjects were studied on two occasions, one shortly after admission to the hospital, the other three weeks later. Group 1 was unmedicated during the first session, whereas group 2 was medicated throughout the study. Three weeks after the start of medication, at the second interview, both recording methods showed a reduction in facial activity and facial expression across all subjects in group 1. The facial action of patients in group 2, however, remained unchanged.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357682     DOI: 10.1055/s-2007-1014412

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  12 in total

1.  [Identification of possible cognizance parameters of "mimic disintegration" in schizophrenia using facial electromyography].

Authors:  K Wolf; S Köppel; R Mass; D Naber
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

2.  Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients.

Authors:  E Fakra; S Khalfa; D Da Fonseca; N Besnier; P Delaveau; J M Azorin; O Blin
Journal:  Psychopharmacology (Berl)       Date:  2008-06-25       Impact factor: 4.530

3.  Keep smiling! Facial reactions to emotional stimuli and their relationship to emotional contagion in patients with schizophrenia.

Authors:  Irina Falkenberg; Mathias Bartels; Barbara Wild
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

4.  Static posed and evoked facial expressions of emotions in schizophrenia.

Authors:  Christian G Kohler; Elizabeth A Martin; Neal Stolar; Fred S Barrett; Ragini Verma; Colleen Brensinger; Warren Bilker; Raquel E Gur; Ruben C Gur
Journal:  Schizophr Res       Date:  2008-09-13       Impact factor: 4.939

5.  Kinematic analysis of facial behaviour in patients with schizophrenia under emotional stimulation by films with "Mr. Bean".

Authors:  Georg Juckel; R Mergl; A Prässl; P Mavrogiorgou; H Witthaus; H J Möller; U Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

6.  Dynamic evoked facial expressions of emotions in schizophrenia.

Authors:  Christian G Kohler; Elizabeth A Martin; Marina Milonova; Peng Wang; Ragini Verma; Colleen M Brensinger; Warren Bilker; Raquel E Gur; Ruben C Gur
Journal:  Schizophr Res       Date:  2008-09-14       Impact factor: 4.939

7.  Facial expression in male and female schizophrenia patients.

Authors:  Gwenda Simons; Johann Heinrich Ellgring; Katja Beck-Dossler; Wolfgang Gaebel; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-09       Impact factor: 5.270

8.  Facial expressivity in the course of schizophrenia and depression.

Authors:  Wolfgang Gaebel; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

9.  Stability of facial affective expressions in schizophrenia.

Authors:  H Fatouros-Bergman; J Spang; J Merten; G Preisler; A Werbart
Journal:  Schizophr Res Treatment       Date:  2012-03-22

10.  Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the Facial Action Coding System: a preliminary study.

Authors:  Giuseppe Bersani; Francesco Saverio Bersani; Giuseppe Valeriani; Maddalena Robiony; Annalisa Anastasia; Chiara Colletti; Damien Liberati; Enrico Capra; Adele Quartini; Elisa Polli
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-18       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.